Dr. Alaa Al-Krush
university of Sulaymaniyah Mexico
Kyrgyz-Russian Slavic University Russia
Azhar University Egypt
Barrington Ainsworth Brevitt
University of the West Indies Mona Jamaica
Shyvin K S
Aster wayanad hospital India
Salwa Hussein Swelam
Minia University Egypt
N C Santosh Kumar
Kakatiya Institute of Technology and Science India
Nien Yue Koh Tan Tock Seng Hospital Singapore
Recommended Global Neuroscience Conferences
Nephrology Congress 2020
Session And Track
The nephrology devices market is driven by technological advancements that are anticipated to serve the market with future growth opportunities. These advancements include inclusion of stem cells, wearable artificial kidneys, combined use of ion-sensitive sensors & electrodes, living membranes, shockwave, and laser lithotripsy.
These technologies serve as efficient methods of renal care, which are capable of improving overall patient health and quality of life. In addition to improved uremic toxin and fluid removal, relatively less hypotension episodes, better control of blood pressure, overall improvement in mineral metabolism, better survival rate, and reduction in hospitalization rates & costs. In addition, these advancements also have a substantial impact on patient’s quality of life through increased volume of dialysate, ultrafiltration capacity, and higher solute clearance.
The unprecedented adoption of unhealthy lifestyle has exerted a major impact on the market, leading to high prevalence of chronic diseases, such as cancer and diabetes, which serve as a contributing factor toward developing kidney and urinary diseases. Moreover, the widening of geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases is expected to impel the demand for highly efficient devices.
The Global market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021.
Asia-Pacific leads the market with a 43 per cent share, followed by North America and Europe
The latest report on the nephrology and urology devices market from Global Data has highlighted how an explosion in diabetes and hypertension combined with aging populations is driving investment to meet patient needs.
In 2016, renal dialysis equipment accounted for over 55 per cent of the market value, at over $17 billion, and this is expected to grow to over $26 billion by 2026.
The renal dialysis equipment market in japan will rise steadily from $5 billion in 2015 to over $11 billion by 2022, representing a Compound Annual Growth Rate (CAGR) of 3.48%.
All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
Abstracts will be provided with Digital Object Identifier by